The Office for Life Sciences of the government of the United Kingdom has designated six new locations in the country as ‘Life Sciences Opportunity Zones’, of which the Harwell Science and Innovation Campus is one.
The Office for Life Sciences of the government of the United Kingdom has designated six new locations in the country as ‘Life Sciences Opportunity Zones’, of which the Harwell Science and Innovation Campus is one.
In a Feb. 20, 2020 press release, Harwell revealed that this designation is one of only seven across the whole country and the only one in Oxfordshire/Thames Valley area. The designations are valid for a period of 10 years and will see the UK government working with Harwell to attract both inward and foreign investment, establish trade agreements, and promote the campus as a world-leading location for companies to establish themselves.
“The life sciences industry contributes over £70 billion [US $90.4 billion] per annum to the UK economy and provides 240,000 jobs. Harwell Campus plays an increasingly important role at the center of this sector,” said Gordon Duncan, partner, Harwell Science and Innovation Campus, in the press release. “We have a unique platform here to help accelerate research and innovation around the country, taking applied research and turning it into commercial outputs using state-of-the-art technologies and applications-this is unparalleled across Europe.”
Source: Harwell
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.